Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR | Market Cap | 24.74M +592.4% |
| Revenue (ttm) | 23.49M +11.1% |
| Net Income | -3.86M |
| EPS | -0.01 |
| Shares Out | 1.25B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,232,853 |
| Open | 0.0188 |
| Previous Close | 0.0184 |
| Day's Range | 0.0184 - 0.0200 |
| 52-Week Range | 0.0030 - 0.2433 |
| Beta | 0.10 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Fidia
Fidia S.p.A., together with its subsidiaries, production and sale of numerical controls and software, high-speed milling systems and after-sales technical assistance. The company offers HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. It also provides software solutions incl... [Read more]
Financial Performance
Financial StatementsNews
Ajay Devgn's legal challenge won't halt proceedings, says Maharashtra FDA chief Tukaram Mundhe on Vimal Elaichi ad controversy
Maharashtra Food and Drug Administration (FDA) Commissioner Tukaram Munde on Sunday said that adjudication proceedings have already been initiated in the Vimal pan masala controversy involving actor A...
Why Doctors Are Last to Know What’s in the Drug Supply
The FDA should create an expedited pathway for clinical tests targeting emerging drug threats, write Dr. Shravani Durbhakula and Jeremy Kourvelas.
FDA show-cause notice on ad is pre-judging, punitive: Actor Ajay Devgn
Ajay Devgn challenges Maharashtra FDA show-cause notice over elaichi ad, calling it prejudged and punitive; Bombay HC hears plea on Nov 4.
'Prejudging, premeditated, punitive': Ajay Devgn hits out at FDA over pan masala ad notice
Ajay Devgn received a show cause notice from the Maharashtra FDA regarding his elaichi advertisement. The notice questioned his endorsement related to Vimal Pan Masala and demanded its removal from hi...
INOVIO Pharma Soars As FDA Grants Accelerated Approval For VOCERYQ In Adult RRP
(RTTNews) - INOVIO Pharmaceuticals (INO) announced Friday that the U.S. Food and Drug Administration granted accelerated approval for VOCERYQ (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-g...
US FDA approves Inovio's treatment for rare throat disease
The US Food and Drug Administration has approved Inovio Pharmaceuticals' treatment for a rare respiratory condition, the regulator said on Friday, marking the company's first approved product.
Ajay Devgn moves HC over FDA’s pan masala ad notice
Ajay Devgn moves Bombay HC after Maharashtra FDA show-cause notice over Vimal Elaichi surrogate pan masala ads; adjudication to proceed amid tobacco ban.
Maharashtra govt suspends four FDA officers, launches dept inquiry against 21 others over irregularities in action against two companies accused of possessing banned tobacco products
Maharashtra suspends 4 FDA officers and probes 21 others over irregularities in raids and action against two firms accused of holding banned tobacco products.
Sensient (SXT) Q3 2026 Earnings Call Transcript
Natural color conversions accelerate as FDA synthetic certifications decline 10% year-over-year.
FDA completes proceedings against Shah Rukh Khan, Ajay Devgn, Tiger Shroff over Vimal ads
In a significant development, the Maharashtra Food and Drug Administration has finalized its investigation into prominent actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff regarding their endorsemen...
Weekly Buzz: ABBV, PFE Win FDA Nod; ARTV Slashes Jobs; DAVI, SGRY Strike Deals
(RTTNews) - The biotech sector stayed active this week, with a mix of regulatory approvals, strategic partnerships, M&A activity, and clinical trial developments.
FDA again bypasses advisers to remove black-box warnings from menopause treatments
Some experts express concern about ‘lack of transparency’ as agency removes warnings on three estrogen patches Three more patches for treating menopause will no longer carry black-box warnings about c...
Exelixis (EXEL) Q3 2026 Earnings Call Transcript
Cabozantinib sales grew 11% year over year as zanzalintinib advances toward FDA decisions.
Tukaram Mundhe Launches Strict Orders For Diwali Sweets, 34 Accused Already Arrested
Maharashtra FDA raided warehouses repackaging expired food as new, seizing spoilt stock worth crores and arresting 34 people ahead of Diwali.
Agios Gets New FDA Goal Date For Mitapivat In Sickle Cell Disease
(RTTNews) - Agios Pharmaceuticals (AGIO) has received a new FDA PDUFA goal date of February 1, 2027, for its mitapivat supplemental application in sickle cell disease.
Sun Pharma's Ilumya Wins FDA Approval For Active Psoriatic Arthritis
(RTTNews) - Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS) said Friday the U.S. Food and Drug Administration (FDA) approved Ilumya for adults with active psoriatic arthritis, expanding its use beyo...
Processa Pharmaceuticals, Inc. Appoints Dr. Sheila Gujrathi as Executive Chair and Announces FDA Clearance of Phase 2 IND for VT-7208
Processa Pharmaceuticals, Inc. announced that on October 27, 2026, Justin Yorke resigned as chair of the board of directors, and on October 28, 2026, the board appointed Dr. Sheila Gujrathi as the non...
MPSC probe hearings open to public; anyone with related info urged to step forward: Mundhe
MPSC inquiry commission hearings at FDA HQ, BKC will be public, says Tukaram Mundhe; candidates can submit affidavits and evidence by Nov 16.
Eloxx Gains FDA Clearance For Exaluren Phase 2 Trial In Genetic Kidney Disease
(RTTNews) - Eloxx Pharmaceuticals, Inc. (ELOX) announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug application for exaluren to treat nonsense-mutation a...
Maharashtra FDA seizes Rs 19.7 crore spices, suspends 84 licences after over 1,000 inspections between April and October, says commissioner Tukaram Mundhe
Maharashtra FDA inspected 1,057 spice units Apr–Oct, seized Rs 19.7 crore masalas and suspended 84 licences; warns against loose spices, steps up Diwali checks.
US FDA proposes new nutrient limits, labeling rules for infant formula
The US Food and Drug Administration proposed new nutrient limits and labeling rules for infant formula on Thursday, as part of its ongoing review of baby formula nutrients.
US FDA issues warning on Medline beds after 2 deaths, 16 serious injuries
The US Food and Drug Administration on Thursday warned of safety risks associated with Medline beds and accessories after the company reported two deaths and 16 serious injuries linked to fire, entrap...
HUTCHMED (China) Limited Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia
HUTCHMED (China) Limited announced that the US Food and Drug Administration has granted Orphan Drug Designation to sovleplenib for the treatment of primary immune thrombocytopenia, an autoimmune disor...
Biotech Stocks Facing FDA Decision In November 2026
(RTTNews) - The FDA's November calendar has more than a dozen PDUFA dates on the horizon, setting the stage for an eventful month in the regulatory landscape.
FDA finds no imports of dodgy enoki mushrooms
The Food and Drug Administration (FDA) has found no imports of enoki mushrooms from Chinese producers recently flagged by the US Food and Drug Administration (FDA) over listeria contamination, but has...